logo
Plus   Neg
Share
Email

PayPal To Waive Certain Fees, Deferring Repayments Amid COVID-19 - Quick Facts

PayPal Holdings, Inc. (PYPL) announced Tuesday a set of relief measures to help its more than 24 million merchants around the world impacted by the coronavirus (COVID-19) pandemic.

The company said it is waiving certain fees and will be deferring repayments on business loans for some of its most affected small business customers.

PayPal is waiving chargeback fees for merchants if their customer files a dispute with a credit card issuer through at least April 30, 2020. It is also extending the window in which merchants must respond to a customer dispute from 10 to 20 days through at least April 30, 2020.

It is waiving fees to instantly withdraw money from a PayPal business account to a bank account, Mastercard Debit or Visa Debit card through at least April 30, 2020.

Additionally, PayPal is doubling the instant cash back reward on eligible purchases beginning April 1 through at least April 30, 2020 in partnership with Mastercard.

"We are taking immediate steps to help our small business customers who are most impacted by the coronavirus pandemic to help them navigate these challenging times," said Dan Schulman, president and CEO, PayPal.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hyundai Motor has launched a new IONIQ brand dedicated to battery electric vehicles, as the automaker is accelerating its efforts to gain a share in the fast-growing global EV market. Under the IONIQ brand, Hyundai plans to introduce three new dedicated electric vehicle models over the next four years. Hyundai is South Korea's largest automaker. Amazon.com, Inc. is in talks with mall operator Simon Property Group, Inc. to use the abandoned anchor departmental stores of JC Penny and Sears at their malls as fulfillment centers, reports said. This is expected to help the e-commerce giant in boosting their last mile delivery, which is the last leg of the delivery process. The U.S. Food and Drug Administration announced the approval of Trevena Inc.'s Olinvyk (oliceridine), a new opioid for intravenous use in hospitals or other controlled clinical settings. Olinvyk is an opioid agonist to manage moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Follow RTT